Cart
sales@molnova.com
Home - Products - Others - Other Targets - AJ2-30

AJ2-30

CAS No. 2700322-79-6

AJ2-30( —— )

Catalog No. M37014 CAS No. 2700322-79-6

AJ2-30 is an SLCl5A4 inhibitor that inhibits TLR9-mediated B cell activation and inhibits MDP transporter.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 117 In Stock
5MG 103 In Stock
10MG 170 In Stock
25MG 353 In Stock
50MG 554 In Stock
100MG 788 In Stock
200MG 1051 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    AJ2-30
  • Note
    Research use only, not for human use.
  • Brief Description
    AJ2-30 is an SLCl5A4 inhibitor that inhibits TLR9-mediated B cell activation and inhibits MDP transporter.
  • Description
    AJ2-30 is a SLCl5A4 inhibitor. AJ2-30 inhibits TLR9-mediated B cell activation. AJ2-30 block endogenous NOD signaling in human and mouse macrophages. AJ2-30 can be used for research of inflammation.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2700322-79-6
  • Formula Weight
    354.45
  • Molecular Formula
    C23H22N4
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 50 mg/mL (141.06 mM; Ultrasonic (<60°C)
  • SMILES
    N=1C=2C=CC=CC2N(C1NCC3=CC=C4C(=C3)C=5C=CC=CC5N4CC)C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Daniel Lazar, et al. Small molecule inhibitors of scl15a4 with anti-inflammatory activity. Patent. WO2021174023.
Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • [Ala144] - PLP (139 ...

    [Ala144] - PLP (139 - 151) A144 - PLP(139 - 151)

  • [Lys3]–Bombesin

    [Lys3]-Bombesin is a biological active peptide. (PET (Positron Emission Tomography) imaging of [Lys3]-bombesin is able to detect gastrin-releasing peptide receptor (GRPR) positive prostate cancer. An immunoconjugate of [Lys3]-bombesin and corresponding monoclonal antibody can specifically induce (CD64)-dependent monocyte and neutrophil-mediated lysis of small cell carcinoma.)

  • (D-Pro2,D-Phe7,D-Trp...

    (D-Pro2,D-Phe7,D-Trp9)-Substance P

Sign In Join Free